famotidine has been researched along with Sjogren's Syndrome in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasama, T | 1 |
| Shiozawa, F | 1 |
| Isozaki, T | 1 |
| Matsunawa, M | 1 |
| Wakabayashi, K | 1 |
| Odai, T | 1 |
| Yajima, N | 1 |
| Miwa, Y | 1 |
| Negishi, M | 1 |
| Ide, H | 1 |
| Tomasko, MA | 1 |
| Luskin, AT | 1 |
1 trial available for famotidine and Sjogren's Syndrome
| Article | Year |
|---|---|
Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome.
Topics: Aged; Aged, 80 and over; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ni | 2008 |
1 other study available for famotidine and Sjogren's Syndrome
| Article | Year |
|---|---|
Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Topics: Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Middle Aged; Parotitis; Ranitidine | 1988 |